IP Library Granted Patent US 8,211,871
Granted Patent B2
US 8,211,871 · App. 11/414,770 · Granted Jul 3, 2012

Topical skin barriers and methods of evaluation thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,211,871
App. No.
11/414,770
Granted
Jul 3, 2012
Kind
B2
Abstract

A topical skin barrier for protecting and promoting healing of skin, and for providing comfort to a patient, comprises a semi-solid hydrocarbon, a water-absorbing compound, and a pain relief agent. The topical skin barrier effectively adheres to skin, affords protection from moisture and waste, provides transparency in use, and is anhydrous and therefore is preservative-free. Methods of in vitro evaluation are for (i) a composition's protection from moisture and waste, and (ii) a composition's adhesion to skin.

Claims (25)

1. A topical skin barrier comprising:

in a range by weight from about 25.0% to about 90.0%, a petrolatum;

in a range by weight from about 5.0% to about 50.0%, a cellulose gum having a degree of substitution between 0.80-0.95; and

one of miconazole nitrate and clotrimazole added to said topical skin barrier;

wherein said topical skin barrier is substantially transparent to permit visual observation of skin under said topical skin barrier.

2. The topical skin barrier of claim 1 further comprising, in a range by weight from about 0.1% to about 20.0%, an agent which (i) improves application slip and (ii) promotes ease of removal of the topical skin barrier from skin to which it has been applied.

3. The topical skin barrier of claim 1 , further comprising, in a range by weight from about 0.1% to about 5.0% tocopheryl acetate.

4. The topical skin barrier of claim 1 , wherein said petrolatum is white petrolatum.

5. The topical skin barrier of claim 2 , wherein said agent is dimethicone.

6. The topical skin barrier of claim 1 , wherein said pain reliever is selected from the group consisting of dibucaine, lidocaine, benzocaine, betamethasone, and tetracaine.

7. A topical skin barrier comprising:

in a range by weight from about 25.0% to about 90.0%, a semi-solid hydrocarbon;

in a range by weight from about 5.0% to about 50.0%, a cellulose gum having a degree of substitution between 0.80-0.95; and

in a range by weight from about 0.5% to about 2.5%, an antifungal agent added to said topical skin barrier to enhance moisture barrier and waste barrier of said topical skin barrier;

wherein said topical skin barrier has effective adhesion to skin and is substantially transparent to permit visual observation of skin under said topical skin barrier.

8. The topical skin barrier of claim 7 , further comprising, in a range by weight from about 0.1% to about 20.0% dimethicone.

9. The topical skin barrier of claim 7 , further comprising, in a range by weight from about 0.1% to about 5.0% tocopheryl acetate.

10. The topical skin barrier of claim 7 , wherein said semi-solid hydrocarbon is selected from the group consisting of petrolatum and white petrolatum.

11. The topical skin barrier of claim 7 , wherein said cellulose gum is carboxymethylcellulose.

12. The topical skin barrier of claim 7 , wherein said antifungal agent is selected from the group consisting of miconazole nitrate and clotrimazole.

13. The topical skin barrier of claim 7 , further comprising:

a pain reliever in a range by weight from about 0.25% to about 20.0% selected from the group consisting of dibucaine, lidocaine, benzocaine, betamethasone, and tetracaine.

14. The topical skin barrier of claim 1 , wherein said topical skin barrier is an anhydrous topical skin barrier.

15. The topical skin barrier of claim 1 , further comprising:

in a range by weight from about 0.25% to about 20.0%, a pain relief agent.

Assignments (4)
PATENT SECURITY AGREEMENT Recorded May 28, 2026
From: MEDLINE INDUSTRIES, LP
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT
Reel/Frame 075643/0462 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2024
From: COLOPLAST A/S
To: MEDLINE INDUSTRIES, LP
Reel/Frame 069577/0858 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2007
From: COLOPLAST CORP.
To: COLOPLAST A/S
Reel/Frame 019224/0691 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2006
From: GERRISH, DONALD L.
To: COLOPLAST CORP.
Reel/Frame 017973/0373 →